Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 108666024 | intron variant | -/GGT | delins | 0.14 |
|
Digestive System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.040 | 6 | 108564420 | intron variant | C/T | snv | 0.30 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 6 | 108564420 | intron variant | C/T | snv | 0.30 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
1.000 | 0.040 | 6 | 108677702 | intron variant | G/A;C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 6 | 108675760 | intron variant | G/T | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.040 | 6 | 108675760 | intron variant | G/T | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 0.040 | 6 | 108675760 | intron variant | G/T | snv | 0.54 |
|
Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 108680839 | 3 prime UTR variant | C/T | snv | 0.53 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 108680839 | 3 prime UTR variant | C/T | snv | 0.53 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 108679539 | intron variant | A/G | snv | 0.54 |
|
Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 108662324 | intron variant | C/T | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
1.000 | 0.080 | 6 | 108591998 | intron variant | T/C | snv | 0.17 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.120 | 6 | 108652895 | intron variant | C/T | snv | 0.55 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.120 | 6 | 108652895 | intron variant | C/T | snv | 0.55 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
0.010 | 1.000 | 1 | 2020 | 2020 | |||||||||
|
0.882 | 0.120 | 6 | 108620265 | intron variant | A/C;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108682786 | 3 prime UTR variant | C/A;G | snv |
|
0.010 | 1.000 | 1 | 2020 | 2020 | |||||||||
|
0.882 | 0.120 | 6 | 108682786 | 3 prime UTR variant | C/A;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108682786 | 3 prime UTR variant | C/A;G | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.882 | 0.120 | 6 | 108682786 | 3 prime UTR variant | C/A;G | snv |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 |